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The Olympics and Paralympic games bring joy to 
millions of people worldwide. This year it was held in 
Rio de Janeiro, Brazil amidst the Zika virus epidemic.  
On 1 February 2016, six months leading to the 
Olympics, the excitement was dampened by the World 
Health Organization declaration of the unprecedented 
vector-borne Zika virus (ZIKV) infection as a public 
health emergency of international concern [1]. At that 
point in time, people in Malaysia also felt the heat but 
had the consolation that the epidemic occurred across 
the Atlantic on the other side of the world. On 27 
August 2016, Singapore reported the first local 
confirmed case of ZIKV infection in the city-state [2]. 
It was only a matter of time that Malaysia reported its 
first confirmed case of ZIKV infection on 2 September 
2016 [3]. A 58-year old woman from Klang, Selangor 
was diagnosed as the first ZIKV case, who had earlier 
visited her daughter in Singapore who was infected by 
the ZIKV. As of 22 September 2016, the number of 
confirmed ZIKV cases in Malaysia has mounted to six 
with both Polynesia and Micronesia strains [4]. The 
occurrence of the disease in our continent brings to light 
how rapidly globalization and free movement of 
population across geographical borders can accelerate 
the arbovirus threat across the globe. 
  The ZIKV is spread through the bite of 
infected female Aedes mosquitoes and evidence has 
shown it can also spread via sexual and blood 
transmission [5]. Most of the cases are asymptomatic or 
subclinical while the symptomatic cases are self-
limiting. Other manifestations include neurological 
(Guillain-Barré syndrome and meningoencephalitis) 
and autoimmune (thrombocytopenic purpura and 
leukopenia) complications. More alarming is the 
association of the virus with infants born with 
microcephaly as a result of pregnant mothers infected 
with ZIKV with the risk of microcephaly ranges 
between 1-13% [6, 7], though the direct causal 
relationship is still under investigation.   
  In line with the international response, 
Malaysia has intensified the surveillance and 
management activities to control its ZIKV epidemic. 
These include clinical surveillance, laboratory 
surveillance, microcephaly and Guillain-Barre 
Syndrome case detection as well as preparedness and 
response at all ports of entry [8]. The public health 
delivery system in Malaysia has improved 
tremendously over the years following lessons learned 
from the emerging and re-emerging infectious diseases 
that affected the country over the recent years. Apart 
from those commendable measures; in light of this 
ZIKV outbreak, there are looming questions even 
though may appear elementary are nevertheless 
pertinent which the healthcare fraternity should address.  
Where do we go from here? What more do we need to 
know and do to help us manage and control this 
outbreak more efficiently and effectively? These 
questions would certainly pose a challenge to our public 
health especially when this arbovirus shares the same 
transmission vector with dengue and chikungunya i.e., 
Aedes mosquito where the authorities in Malaysia are 
still struggling to achieve a satisfactory control level in 
the country. 
  What shall we do?  We need a paradigm shift. 
We need to look at the re-emergence of ZIKV in a 
bigger perspective and manage it accordingly. Thus, 
instead of reacting merely to the notified ZIKV cases, 
we need to start strategizing how the transmission 
dynamics of the arbovirus family can be altered; this 
possibly means to look out of the box for the solutions. 
The conventional measures for prevention and control 
should also be complemented with two other elements 
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which are often neglected and underestimated in most 
outbreak response i.e., effective communication and 
social mobilization [9]. We must actively engage in 
communication with the public to hasten the 
containment by using all available forms of social 
medium. With tons of information about the virus in the 
media, the message should emphasize more on health 
education; empowering community on the case reports, 
transmission routes and infection complications rather 
than general statements on impact and world reaction 
towards ZIKV [10]. Only then social mobilization, 
which is commonly underutilized, may help mitigate 
the social and economic impact during an outbreak. An 
informed public understands the limitation and the need 
for the community. Only then we will appreciate the 
ripple effects - they will bring the community on board, 
educate the community to actively participate in the 
outbreak management, and share the responsibility as 
well as the outcome. Even when the community is 
faced with great anxiety, an informed public would be 
able to understand and support any move or decision 
made by the authorities concerned. 
  Of late, the controversy which surrounded 
ZIKV in Malaysia involved the ethical issue in dealing 
with termination of pregnancy in women with possible 
ZIKV-related fetal brain abnormalities. This was 
following a statement made by the Mufti of the Federal 
Territory, saying that Muslim women could abort their 
pregnancies if they were infected by the Zika virus to 
avoid the adverse effect on the lives of their families or 
the baby itself [11]. In Malaysia, the current law does 
not provide for abortion for pregnant mothers infected 
with Zika unless the pregnancy poses a threat to the 
mother’s life [12]. The recent Centres for Disease 
Control guideline does not include pregnancy 
termination as an option in managing suspected or 
confirmed Zika infection. It advocates monitoring the 
pregnancy with serial fetal ultrasounds in suspected or 
inconclusive cases and retest for ZIKV when ultrasound 
suggests abnormalities consistent with Zika infection 
and fall short in mentioning the alternative path of 
termination of pregnancy [13]. On the other hand, 
World Health Organization guideline mentions subtly 
on the discontinuation of pregnancy as a possible next 
step in the management of pregnancies with the 
likelihood of foetal brain abnormalities and states that 
women who wish to discontinue their pregnancy should 
receive accurate information about their options to the 
full extent of the law [14].  The failure to include 
guidelines on the option of safe, legal termination of 
pregnancy in Zika-response strategies is not only an 
issue of reproductive rights but also an issue of 
reproductive justice [15]. At the time of writing, it is 
learned that the Ministry of Health of Malaysia will 
hold a discussion on the matter with the National Fatwa 
Council regarding termination of pregnancy for women 
infected by the Zika virus in order to reach a consensus. 
Irrespective of the outcome of the fatwa, we are in the 
opinion that whether a woman who wishes to carry her 
pregnancy to term or discontinue the pregnancy should 
be offered appropriate counselling so that she, together 
with her partner, will be able to make a fully informed 
choice on the next step of action. 
  Despite being a re-emerging disease, there is 
still much evidence required to effectively manage and 
control the ZIKV outbreak. The disease behaviour 
remains dynamic, and a concerted effort by the health 
authorities and policy makers in implementing the 
appropriate dynamic alignment to meet the challenges 
is imperative. It also requires heightened public 
awareness of personal responsibility which is of 
paramount importance. The public health preventive 
strategies remain the cornerstone in the control of this 
mosquito-borne disease. 
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INTRODUCTION 
The Lancet published this early report by Andrew 
Wakefield et al on February 28th, 1998; “12 children 
(mean age 6 years [range 3–10], 11 boys) were 
referred to a paediatric gastroenterology unit with 
history of normal development followed by loss of 
acquired skills, including language, together with 
diarrhoea and abdominal pain….Onset of behavioural 
symptoms was associated, by the parents, with 
measles, mumps, and rubella vaccination in eight of 
the 12 children” [1].  
 This article flipped the concrete evidence-
based success story of vaccination into an emotionally 
charged and debatable topic of the century. It was only 
after a decade of much larger studies which failed to 
replicate their findings that it became evident that there 
was no association between Measles, Mumps and 
Rubella (MMR) vaccination and autism. While it is 
well known that scientific investigations can be wrong 
but what is unacceptable here is the fraudulent 
research practice, in this case, the presentation of 
wrong data, and the lead author’s overwhelming 
undeclared conflict of interest. The aftermath could not 
be more devastating, Lancet withdrew the paper fully 
and the loss of his license to practice medicine in the 
UK in 2010.  
 
THE WIDER IMPLICATION 
The MMR-Autism link saga to the medical world 
meant that more research, time and money were 
poured to refute the study and also to expose the fraud 
but the repercussions however were not only confined 
to the medical profession. The greatest damage was the 
appalling tangential increase in vaccine refusal among 
parents worldwide which fuelled the measles outbreak 
across the United Kingdom (UK), United States and 
Canada in the year 2008 and 2009. UK for example, 
saw a drop in vaccination rates from 87.4 percent to 
79.9 percent in the year 2000-01 and 2003-04 
respectively and not surprisingly, a dramatic increase 
in measles cases in the UK in the year 2007-08, which 
was equal to the combined total measles notifications 
for the past decade [2]. 
 As the news coverage on the controversy 
intensified, and coupled with advancement of 
technology in the social media network, the public 
perception on vaccination has suddenly changed, the 
most successful health revolution in the 20th century is 
now at stake. Seemingly increasing public distrust and 
confusion over the safety of vaccination were echoed 
and mischievously elaborated geographically, reaching 
out to most of the third world countries including 
Malaysia causing the dreaded domino effect of 
declining immunisation rates in many countries 
including our own. 
 
THE BLIGHT ON OUR SUCCESS 
We began our free national immunisation programme 
for Diphteria, Pertussis and Tetanus in 1958, the 
vaccination for Tuberculosis, Polio and Measles were 
gradually added into the immunization schedule 
between the years 1960 to 1980s. Malaysia has done 
very well since, based on the latest Millenium 
Development Goal (MDG) report in 2015, we have 
reached almost full coverage for one-year-old intake of 
the Measles, Mumps and Rubella (MMR) vaccine. The 
rate of intake of this vaccine was initially 70.1% in 
1990, with massive improvement to 94.3% (2008) and 
95.2% in 2013 [19], validated by a recent study in 
2016 from a rural clinic in Sabah at 98.5% [29]. 
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Lurking behind this success however is the rising trend 
of parents refusing to vaccinate their children. We now 
notice an increase in the number of vaccine refusal 
from 470 cases in 2013 to 648 in the following year 
and 1292 in 2015. Among the states in Malaysia, 
Kedah state recorded the highest number of vaccine 
rejection cases with steady rise from 239 cases in 2014 
to 318 cases a year later.  
 Why is this happening? Data from the state of 
Kedah health statistics suggested that the major cause 
for the refusal was the concern regarding the vaccine 
contents and their religious permissibility (halal). This 
is supported by a cross-sectional study in 2013 done in 
Perak that showed the main reasons for parental 
immunisation refusal were preference to alternative 
treatment (75%), assumption that vaccines have no 
effect (37.5%) and apprehension on the vaccine 
contents (25%), other reasons included not being 
informed regarding vaccination from health 
practitioners, information from family members and 
media, religious influence, personal belief and long 
waiting time in the clinic [18].  In this study the refusal 
rate was 8 per 10,000 children per year and 
immunisation defaulter rate was 30 in 10,000 children 
per year. Vaccine refusal could also be caused by 
deferral which could be due to either ill infants or 
parents missing the schedule or appointments [17].  
 The number of vaccine preventable diseases 
has also showed steady increment for the past few 
years, in tandem with the decrement of immunisation 
rates. Measles cases in Malaysia has quadrupled from 
195 cases in 2013 (6.6 cases per million population) to 
794 cases up till September 2016 (34.7 per million 
population). This is certainly a blight on our success 
and it pushes us off track from the MDG target of 
global measles elimination by 2015. 
 
APPREHENSION OF VACCINE CONTENT 
Certain chemicals are present as ingredients in the 
vaccines to ensure safety and effectiveness of the final 
products. These substances naturally exist in the 
environment and only become toxic if they reach or 
exceed a certain threshold. 
 Among chemicals used in vaccine preparation 
include thimerosal (mercury), which is an organic 
compound containing ethylmercury. Its primary role is 
to prevent bacterial and fungal contamination and has 
been used as vaccine preservative since 1930's [30]. 
 Virtually all vaccines are now mercury-free; 
and even if present its potential harmful effect is 
almost negligible as the chemical content in the 
vaccine is extremely low. 
 Aluminium is another compound used in 
vaccine preparation. It acts as an adjuvant to enhance 
the immune response to the vaccine antigen [30]. 
Exposure to aluminium from vaccines is well below 
the current minimum risk level of 2.0 mg/kg per day 
[30]. Interestingly, the content of aluminium is higher 
in breast milk compared to vaccines [31] as well in 
certain medications such as antacids [31]. 
 However, another reason of apprehension that 
is being used as bone of contention by anti-vaccination 
campaigners is the permissibility (halal) of the vaccine 
contents. 
 
THE ISLAMIC VIEWPOINT 
The objectives of Islamic law (maqasid shariah) are 
the preservation of five fundamental elements in a 
person; religion, life, lineage, intellect and property.  
Correspondingly, the maxim of Islamic law (Qawaid 
al Fiqh) adheres to the principle of avoiding harm, 
thus taking steps towards maintenance of health and 
this includes vaccine administrations to prevent serious 
and life-threatening illnesses among children are in 
accordance to these principles.  
 As stated earlier, the main religious 
consternation regarding vaccination among Muslims 
parents revolves around the issue of permissibility 
(halal) of the vaccine contents. In this regard, many 
scholars in Islamic Jurisprudence have in fact issued 
clear ruling (fatwa) regarding the permissibility of 
most vaccines used as part of national immunisation 
programmes worldwide, including Bacillus Calmette-
Guerin (BCG), Hepatitis B, Diphtheria, Tetanus, 
Pertussis and Rubella vaccines [20-24].  
 Differences of opinion however does exist 
among the scholars regarding vaccines that have 
substances derived from pork, which are forbidden 
(haram) in Islam, being used during their 
manufacturing process. As an example, for the 
production of oral polio and rotavirus vaccines, trypsin 
enzyme of porcine origin is used during production to 
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dissociate the virus from cultured cells, but it is later 
removed through the process of microfiltration.  The 
use of this substance however has led the Malaysian 
Fatwa Committee National Council of Islamic 
Religious Affairs in 2008 to issue a ruling that the use 
of Rotavirus vaccine is forbidden, other religious 
considerations by the council include the availability 
of an alternative trypsin source and the absence of an 
urgent state (darurah) for its use. But other opinion 
does exist which can be considered to be more in tune 
with the spirit of Islam that discourages complexity in 
performance of religious duties, the ruling from the 
European Council of Fatwa & Research in 2003 led by 
Yusuf al-Qardhawi. He concluded that the use of oral 
polio vaccine was permissible based on the following 
reasons; the negligible amount of trypsin used in the 
vaccine preparation, the fact that trypsin is filtered and 
thus not detectable in the final vaccine, and finally 
what is forbidden (haram) is made permissible in the 
state of necessity. As a result of this ruling, many 
Muslim countries such as Saudi Arabia, Bahrain, 
Yemen, Qatar, Iraq, Morocco, Sudan and Pakistan [20] 
have incorporated Rotavirus vaccine that uses porcine 
trypsin in their national immunisation programmes. 
 
THE WAY FORWARD 
This requires efforts by all relevant stakeholders, 
government and non-government, to reverse the trend 
we see locally as well as worldwide. One great stride 
forward was the WHO approved Global Vaccine 
Action Plan, a framework to prevent millions of deaths 
by 2020 through more equitable access to existing 
vaccines for all peoples in all communities [30]. The 
aims here are to strengthen routine immunisation to 
meet vaccination coverage target, accelerate control of 
vaccine-preventable diseases as well spur research for 
development of new and improved vaccines [30]. 
 Healthcare providers are undoubtedly the front 
liners in educating the parents and clarifying any 
doubts which may prohibit vaccine adherence among 
them.  We know that counseling parents with clear 
information about the risks and benefits of vaccines, 
and taking advantage of clinical consultation visits for 
explanation of immunisation are among the most 
effective strategies suggested to achieve this [31]. In 
Malaysia, forums and educational talks to the general 
public are actively organised by the Malaysian 
Ministry of Health and other non-governmental 
organisations to reach for these parents at all levels and 
localities. Besides that, social media is also very 
effective and is a borderless educational platform to 
reach the community.   
 Finally, the history of vaccination had been a 
great success story of the last century, Measles 
vaccination alone has been estimated to have helped 
save 17.1 million lives in the year 2000 [27]. Lack of 
knowledge on the issue compounded with 
contradictory information in social media have led to 
the disruption of herd immunity that previously had 
been the gate keeper in protecting our children from 
vaccine-preventable disease. We must do all we can to 
ensure it remains a success. 
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THE TRADITIONAL CURRICULUM 
Medical education in Malaysia has evolved in the past 
50 years since independence. This paper highlights the 
various stages of curriculum development that were 
made to meet the needs of the developing country. 
 Malaya was under British rule between the 
18th and the 20th Centuries. British Malaya as it was 
then known comprised of the Peninsular States and the 
Straits Settlements of Penang, Malacca and Singapore.  
Western medicine was introduced to the then Malaya 
in Singapore, with the setting up of the first medical 
school in 1907. It was called the Government Medical 
School and later became known as the King George 
VII College of Medicine in Singapore. In 1910 the first 
batch of seven male Medical graduates received their 
Licentiate in Medicine and Surgery (LMS) [1]. 
 In 1949, the University of Malaya was 
established, based in Singapore, with a branch set up in 
Kuala Lumpur in 1959.  In 1961, both governments of 
Singapore and Malaya agreed and passed legislation in 
Parliament to make the Kuala Lumpur Campus an 
autonomous body known as the University of Malaya; 
with its own medical school and teaching hospital.  
Thus in 1962, the government approved the setting up 
of  the University of Malaya Medical Faculty, together 
with its teaching hospital, in the Klang Valley. The 
Faculty became fully functional in 1964 with the first 
intake of 64 medical students. After the hospital was 
built, the whole complex was named the “University of 
Malaya Medical Centre (UMMC)”, with facilities for 
undergraduate medical teaching, hospital services, the 
nursing school and other ancillary services put in place 
[2].  
 Professor Thumboo John Danaraj who was 
then Professor of Medicine in the Medical Faculty at 
the University of Singapore, was appointed as 
Founding Dean of the Medical Faculty, University of 
Malaya in Kuala Lumpur [3].   With his appointment, 
the process of “head hunting” and appointment of 
academic staff began together with the selection of 
potential students for the first academic session.  
 It was mandatory that the Faculty get relevant 
and competent professionals to start the ball rolling.  
These medical academicians came from different parts 
of the globe, including Sri Lanka, Canada, Singapore 
and the UK (Figure 1). 
 
 
Figure 1 The founding teachers: Faculty of Medicine, University of 
Malaya, 1965 (Courtesy of the late Prof. TJ Danaraj). 
 
 
With these academicians on board, the toiling 
of planning and designing of the medical curriculum 
started since the first batch of medical students was 
scheduled to enter the medical school in 1964. 
 Globally, the medical curriculum followed the 
traditional didactic teaching of basic sciences 
comprising of anatomy, physiology and biochemistry 
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in the first year of undergraduate medical course. In 
the second year, the subjects of pathology, 
pharmacology, medical microbiology and parasitology 
were introduced. This was interspersed with topics on 
communicable diseases and principles of social and 
preventive medicine (SPM).  The thrust of the 
undergraduate curriculum then was in the various 
aspects of issues related to social and preventive 
medicine.  This was deemed to be important because 
the newly formed Malaysia, for the most part, was still 
mostly rural. 
 Professor Danaraj, having had experience as 
an academician in Singapore, felt that the didactic 
teaching of “dry” basic science subjects may not be 
perceived as interesting and relevant by the medical 
students.  Thus, early on in the undergraduate medical 
curriculum, he introduced the clinical correlation 
classes (CCC) with clinical cases brought to the 
auditorium to demonstrate the physical signs and 
correlate them with basic science topics that were 
learnt during the previous week (Figure 2).  This made 
the preclinical students understand the importance of 
basic medical science subjects in order to be able to 
explain the symptoms and the development of physical 
signs when disease occurs. 
 
 
Figure 2 Clinical Auditorium, University of Malaya Medical Faculty. 
Clinical integration with patients starts in year 1 (CCC) (1967) [Courtesy of 
the late Prof. TJ Danaraj]. 
 
 
This was perhaps the earliest change in the 
curriculum to facilitate the teachers to think about 
possibilities of making basic science “dry topics” more 
interesting to the students. This gradual introduction of 
clinical medicine into basic science “preclinical years” 
and vice versa in the clinical years was perhaps the 
beginning of integrated teaching and the evolution of 
the undergraduate medical curriculum in Malaysia in 
the late 1980’s.   
 The clinical years begin from years 3 to 5 with 
rotations in general medicine, surgery, paediatrics 
orthopedics and obstetrics and gynaecology. In the 
clinical years, the integration of basic sciences in the 
form of clinico-pathological case (CPCs) discussions 
in the final year, sets the stage for future developments 
in the undergraduate curriculum. The clinical postings 
and the CPCs were meant to expose the students to 
develop their critical and analytical thinking skills 
during their clinical clerkships. Thus, learning to make 
reasonable diagnoses based on patho-physiological 
processes that had occurred, with minimal 
investigative procedures. This was meant to prepare 
them for their general medical service as medical 
officers in the rural areas, and also providing them 
with the basics for future career development. 
 
NATIONAL STRATEGIES TO IMPROVE 
HEALTH CARE FOR THE POPULATION 
Let us now look at the needs of the country then, and 
how the medical schools were tasked by the 
Government to contribute towards improving the 
health services in the then rural Malaysian society. 
 During the British Administration of the then 
Malaya, the legacy left behind by the British was a 
network of health services that extended to the really 
remote parts of Peninsular Malaya [4], as depicted in 
Figure 3. 
  When Malaya had her independence in 1957, 
the health programs were somewhat coordinated 
although there was a gross deficiency of doctors to run 
the district hospitals and the general hospitals. 
Healthcare then was provided at best by the hospital 
assistants (now known as medical assistants, MA).
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Figure 3 Network of Government run Health Care Services (Legacy from the British Rule of Malaya). a) Rural health unit. b) Replica of the original photo 
(Courtesy of the late Prof. TJ Danaraj). 
 
During this period the teaching of medicine 
closely followed the British medical education system 
that was practiced in the UK.  In those early days, the 
teaching of medicine was by apprenticeship with some 
knowledge of basic sciences to explain the symptoms.  
 Then came the didactic (traditional); and 
scientific discipline model. This preceptor-ship had 
advantages especially when there was as yet no formal 
structured curriculum mapping. To this day, clinical 
mentoring and preceptor-ship is practiced to some 
extent in the clinical ward rounds with bedside 
teaching.  The concept of mentoring and development 
of clinical acumen was very apt in clinical practice; 
both during the undergraduate days and continues in 
the world of medical academia to this day.  This is an 
art that is slowly dying with the advent of investigative 
medical practices.  
 While doctors have to know how to use 
modern investigative tools, clinical acumen is still 
required, to be able to make reasonable diagnosis and 
institute treatment; to be able to determine what 
investigations are appropriate and when referrals are 
necessary. This is so because government-sponsored 
medical graduates face compulsory service that may be 
in rural areas where there is scarce   advanced 
investigative tools to aid them in making the diagnosis.  
 In the 1990’s with the inevitable trend of 
producing more specialists, it was deemed necessary 
for the Ministry of Health to ensure that there will be 
enough primary care providers and general physicians 
who would approach patients in a holistic manner.  
This was tasked to the universities to take the lead to 
develop programs to train medical officers as 
generalists and family and primary care physicians.   
 Medical schools in Malaysia, in developing 
their medical curriculum, need to address these issues 
and tailor-make the curriculum to suit the healthcare 
needs of the country. 
 
To be continued in Part 2: The Blended 
Curriculum  
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INTRODUCTION 
Worldwide estimates of the yearly incidence of 
pneumonia in children aged <5-years range from 120 
to 160 million, with more than 99% occurring in 
resource-limited nations [1]. Pneumonia is one of the 
commonest causes of admission in children and a 
significant contributor to morbidity and mortality in 
both developed and developing countries [2]. Although 
the use of appropriate antibiotics has significantly 
reduced the number of complications arisen from 
bacterial pneumonias, severe invasive complications 
such as cavitary necrosis, abscess formation, pleural 
effusion or empyema are still encountered in clinical 
practice [3, 4].  
Recently, an increasing number of invasive 
pneumonia cases caused by Streptococcus pneumoniae 
have been reported in children [5-6]. Mycoplasma 
pneumoniae, on the other hand, has also been reported 
to cause para-pneumonic effusion, and empyema in 
children [7]. Currently in Malaysia, nationwide exact 
figures of invasive pneumonia cases in children have 
not been established. Nevertheless, hospital-based 
studies had been performed and showed that 
Streptococcus pneumoniae was the most common 
responsible pathogen [8, 9].  This report highlights the 
importance of accurate clinical management to 
improve the outcome in invasive pneumococcal 
pneumonia with massive empyema in children. It also 
highlights the fact that despite the availability of 
antibiotics, readily available treatment and prevention 
programmes we still encounter cases with severe 
complications of pneumonia. There is a need for 
increase public awareness of the availability of 
pneumococcal vaccination. 
 
CASE PRESENTATION 
A 2-year-4-month old Chinese girl was referred from a 
private medical centre with the complaints of fever for 
8 days and intermittent cough for 2 weeks. Fever was 
high grade, ranging from 38.5 ˚C to 40 ˚C. Cough was 
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productive, worse at night and associated with post-
tussive vomiting. Oral intake and urine output were 
both reduced. Both her father and babysitter had 
history of cough. On examination, she was slightly 
pale and irritable. Her weight was 10 kg (just below 3rd 
centile), temperature 38.4˚C, pulse rate 188 beats per 
minutes, blood pressure 96/60 mmHg, respiratory rate  
46 breaths per minutes without recessions, and blood 
oxygen saturation (SpO₂) 100% under nasal prong 
oxygen 2L/min. Reduced air entry and dullness on 
percussion were noted over the left lung. Right lung 
examination was normal.  
 Her initial investigations revealed 
haemoglobin (Hb) 10.8 g/dl, total white cell count 
(WCC) 24.17x10⁹/L, (neutrophil 56.8%, lymphocyte 
26.7%), and platelet 599x10⁹/L. C-reactive protein 
(CRP) was 26.20 mg/dl on admission. Mycoplasma 
pneumoniae antibody level was noted to be high with 
1:320 titre via particle agglutination test. Sputum for 
acid fast bacilli (AFB) was negative for 3 consecutive 
days. Adenovirus, influenza A & B, parainfluenza 1, 2, 
and 3, and respiratory syncytial virus (RSV) were not 
detected from the naso-pharyngeal aspirate (NPA) and 
no growth was obtained on sputum culture. Serum 
glucose, renal and liver functions were all normal.  
 Chest radiograph (CXR) on admission, which 
revealed homogeneous opacity on the left with 
obliteration of left costophrenic angle and mediastinal 
shift, was shown in Figure 1.  
 
 
Figure 1 Chest x-ray on admission 
 She was started on IV benzylpenicillin 
100,000 U (100,000U/kg/dose) 6 hourly and IV 
ceftriaxone 500mg (50mg/kg/dose) 12 hourly to ensure 
adequate gram positive as well as gram negative 
coverage. Chest ultrasound revealed moderate to gross 
pleural effusion with septations on the left lung, for 
which left thoraco-centesis with pigtail tube insertion 
was performed. A total of 150ml pus was drained on 
the first day, and continuously draining for the next 12 
days. The exudative fluid was macroscopically cloudy 
with occasional pus cells under microscope; however, 
no organism was seen on gram stain. Cell count 
showed RBC: 10 cell/mm³, WBC: 20 cell/mm³ 
(predominantly: polymorphs) with no growth on 
culture. Pleural fluid cytology showed inflammatory 
cells with neutrophils predominant and no atypical 
cells. Streptococcus pneumoniae was detected via 
polymerase chain reaction (PCR) test for 
Streptococcus pneumoniae genome in the pleural fluid. 
  The above two antibiotics were continued for 
2 weeks and then changed to syrup cefuroxime for 
another 4 weeks (a total of 6 weeks antibiotic 
treatment). Syrup clarithromycin 75mg (7.5mg 
/kg/dose) twice a day was also given for 1 week, 
started from day 3 of admission, after obtaining the 
positive serology result of Mycoplasma pneumoniae. 
One course (5 days) of intrapleural urokinase 40,000 
units in 40 ml of normal saline 12 hourly was also 
administered to breakdown the septations. She was 
also prescribed syrup multivitamin 2.5ml OD, folic 
acid 250mcg (2.5ml) OD, and ferrous ammonium 
citrate 3ml OD in view of low Hb level, and 
hypochromic microcytic anaemia with pencil shaped 
cells seen on peripheral blood films. Low serum iron 
level with high total iron binding capacity was also 
suggestive of iron deficiency anaemia. 
 Repeated chest ultrasound on day 10 of 
hospitalization revealed residual left pleural fluid 
collection measuring 0.5cm x 0.9cm in maximal depth, 
with echogenic debris and strands within it. CXR on 
day 10 post treatment showed improvement with 
residual left pleural effusion (Figure 2). The repeated 
CRP and WCC also showed marked reduction. The 
pigtail tube was hence removed on day 12 of 
admission and she was discharged with oral 
antibiotics. She was regularly followed up in our 
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outpatient clinic and was last seen 2 months ago with 
full recovery and no residual findings. 
 
 
Figure 2 Chest x-ray on day 10 of treatment  
 
DISCUSSION 
Invasive pneumococcal disease (IPD) is defined as an 
acute and a serious communicable infection confirmed 
by the isolation of Streptococcus pneumoniae from a 
normally sterile sites (eg, blood, cerebrospinal fluid, 
pleural fluid, joint fluid or pericardial fluid)[10]. 
Children with IPD present severely ill as a 
consequence of pneumonia, septicaemia and 
meningitis. The commonest pathogen to cause 
community-acquired bacterial pneumonia in children 
is Streptococcus pneumoniae. A recognised and 
common complication of pneumococcal pneumonia is 
pleural effusion and empyema[11]. Our patient showed 
evidence of the presence of Streptococcus pneumoniae 
antigen in her pleural fluid which fullflled the criteria 
for invasive pneumococcal pneumonia, complicated by 
empyema.  
 An increase in complications of pneumonia 
has recently been recorded in children’s population, 
with Streptococcus pneumoniae being the predominant 
cause[5,8,12,13]. However, there was a recent case 
report on a large pleural effusion with empyema 
caused by Mycoplasma pneumoniae requiring chest 
tube drainage for more than a week[14]. Clinicians 
should be aware of the potential complications of these 
causal organisms while treating children with 
pneumoina, so that early diagnosis and appropriate 
therapy can be instituted. Typically, the clinicians 
should alert the possible complications of pneumonia 
such as pleural effusion and empyema if there is a 
persistent fever after 48 hours of proper antibiotics, 
together with a change in physical signs. In our case,  
patient had high fever with productive cough for more 
than 1 week and had received treatment in a private 
medical centre. However, her condition did not 
improve necessitating suspicion of the presence of 
complications. Therefore, appropriate investigations 
including blood investigations, CXR and chest 
ultrasound are warranted, as early as possible, to 
confirm the possibility of developing parapneumonic 
effusion and empyema. 
 Parapneumonic effusions are more frequent 
compared to true empyema. Parapneumonic effusions 
could be under-diagnosed and empyema can occur 
within 7 days of the initial fluid collection[15]. 
Empyema is, by definition, the collection of pus in the 
pleural space. According to American Thoracic 
Society, it has been divided into 3 stages.They are: 
(1)Exudative – in which a sterile exudate accumulates 
in the pleural space with low white cells; (2)Fibrino-
purulent - where pus is present with an increase in 
cellular counts; and (3) Organised - in which the 
pleural space is filled by a thick exudate with heavy 
sediment and there is a formation of thick peel due to 
fibroblast proliferation[16,17]. 
 Investigations, at initial cannulation, should 
include white cell counts, CRP levels, serological 
testing for mycoplasma and blood culture for any gram 
positive as well as gram negative organisms. Repeated 
blood testing should be considered for cases with 
persistent fever, or if there is a concern of patient not 
responding to appropriate treatment. Pleural fluid 
should be sent for microscopy, culture including 
Mycobacterium tuberculosis, PCR test of suspected 
organisms such as Streptococcus pneumoniae and 
cytology. Chest ultrasound is the investigation of 
choice to be performed for all children with doubtful 
para-pneumonic effusion and empyema. A 
computerised tomography (CT scan) of thorax should 
be considered for cases; if children have failed to 
respond to proper treatment, or if there is any doubt of 
different pathologies[18].  
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 Choice of antibiotics should also adhere with 
the national guidelines and hospital policy. According 
to Infectious Diseases Society of American (IDSA) 
guidelines, benzylpenicillin is the drug of choice for 
Streptococcus pneumoniae with minimal inhibitory 
concentrations (MIC) for penicillin ≤ 2.0 ug/mL and 
ceftriaxone or cefotaxime should be given for those 
with MIC ≥ 4.0 ug/ml and resistant to penicillin[19]. 
According to Paediatric Protocols for Malaysian 
Hospitals, benzylpenicillin is to be given as a first line 
drug in hospitalised cases with pneumonia and 
cefuroxime or cefotaxime as a second line 
antibiotic[20].  
 As a general guideline, benzylpenicillin and 
ceftriaxone are not often combined but our aim of 
using ceftriaxone in this case was to cover for other 
gram negative organisms although it can also be used 
for Streptococcus pneumoniae.  There are other reports 
in the literature where this combination has been used 
to treat complicated pneumonia with effusion and 
empyema [21,22]. In severe cases of pneumonia, 
parenteral therapy combining second or third 
generation cephalosporins and macrolides should be 
administered[20,23]. The mortality was lower (p 
0.004) for those who received a β-lactam–containing 
combination regimen as compared for those who 
received a β-lactam as monotherapy among critically 
ill patients with bacteraemic pneumococcal illness 
[23].  
 A high index of suspicion for Staphylococcal 
infection is also required due to rapid deterioration and 
significant risk of mortality. If radiological features 
such as multilobar consolidations, pneumatoceles and 
spontaneous pneumothorax are present, high dose of 
cloxacillin (200 mg/kg/day) for a longer period should 
be given to cover for Staphalococcal aureus[20]. 
Upgrading to second or third line antibiotics needs to 
be considered especially in cases with no signs of 
recovery, and patients remain ill with spiking 
temperature after 48 - 72 hours of initial treatment[20]. 
 All children with empyema should be ideally 
managed by, or in discussion with, respiratory 
paediatricians together with paediatric surgeons and 
transferred to a tertiary paediatric centre, if feasible. 
The infusion of intrapleural fibrinolytics such as 
urokinase or tissue plasminogen activatorthrough chest 
drains can shorten the hospital stay in comparison with 
chest drain alone[24].  
 Fibrinolytics act by breaking down fibrin 
bands causing loculation of the empyema; and hence, 
drainage of the infected material is improved through 
the chest tube and thereby pleural circulation can be 
re-established[24]. Our case markedly improved by 
pigtail chest tube drain together with intrapleural 
fibrinolytic therapy using urokinase and prolonged use 
of appropriate antibiotics. She did not require any 
invasive surgery like open thoracotomy or video 
assisted thoracoscopic surgery (VATS) which should 
be considered if no clinical improvement. 
 Several interventions to reduce community 
acquired pneumonia include frequent hand-washing, 
promoting breastfeeding, reducing exposure to other 
children, avoiding tobacco smoke, and 
immunization[25]. The widespread use of 
pneumococcal immunization has reduced the incidence 
of IPD[26]. Currently, three types of conjugate vaccine 
are available, such as 7-valent Pneumococcal 
Conjugate Vaccine (PCV7), PCV 10 (Synflorix) and 
PCV 13 (Prevenar 13). PCV7 can prevent the seven 
different serotypes 14, 6B, 19 F, 23 F, 18 C, 4, 9V. 
Synflorix (PCV10) constitutes the seven serotypes in 
PCV7 plus the serotypes 1, 5 and 7F, whereas, 
Prevenar 13 (PCV13) includes the serotypes of PCV10 
in addition to serotypes 3, 6A, and 19 A.  
 In Malaysia, 19F is the most common 
serotypes of Streptococcus pneumoniae causing IPD 
followed by 19A, 14 and 6B [9,27,28,29]. Hence, 
pneumococcal vaccination, by using these vaccines, 
can reduce the risk of developing IPD cases in 
Malaysia. These vaccines are available in the private 
medical centres and have not been introduced in the 
national immunisation schedule to date. However, 
discussion to add this vaccine into the national 
immunisation programme is currently ongoing. In 
many developed countries, pneumococcal vaccines 
have already been included in the national 
immunization schedule to reduce the incidence of IPD 
in infants and children [30, 31, 32, 33, 34]. Our patient 
did not receive the pneumococcal vaccine due to the 
lack of awareness of availability of the vaccine 
although recommendations for pneumococcal 
vaccination, even in children without underlying 
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medical illnesses, are usually made to parents to 
reduce such complications. 
 
CONCLUSIONS 
In conclusion, although the use of appropriate 
antibiotics has significantly improved the outcome of 
pneumonia, severe complications such as massive 
empyema are still encountered. Timely and accurate 
management including the use of thrombolytic agent is 
vital to ensure the optimal outcome and reduce the 
need of invasive procedures if it has developed. Public 
awareness of pneumococcal vaccination in infants and 
children is also essential to reduce such complications.  
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